SEMMA THERAPEUTICS
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for the development of a cell-based therapy for diabetes. Ongoing research at Semma Therapeutics is focused on combining these proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. Semma Therapeutics is working to bring this new therapeutic option to the clinic and improve the lives of patients with diabetes.
SEMMA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.semma-tx.com
Total Employee:
51+
Status:
Active
Contact:
(857)529-6430
Total Funding:
163 M USD
Technology used in webpage:
Google Maps CSC Global DNS CDNS Network
Similar Organizations
Rgenta Therapeutics
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
Rodin Therapeutics
Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.
NFlection Therapeutics
NFlection focuses on the development of novel therapies to address the needs of patients.
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
ViewPoint Therapeutics
ViewPoint Therapeutics is a developer of crystallin stabilizers intended to prevent and treat cataracts and presbyopia.
ViAqua Therapeutics
ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.
Valo Therapeutics
Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Mersana Therapeutics
Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Arsenal Medical
Arsenal Medical develops novel products that improve local therapy for injuries and diseases.
Aleta Biotherapeutics
Aleta Biotherapeutics focuses on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted.
Avivomed
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
Aeglea BioTherapeutics
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Ascletis
Ascletis is a specialty therapeutics company developing therapeutics for the treatment of cancer and infectious diseases.
Aquyre Biosciences
Aquyre Biosciences provides tissue adequacy assessment thru tissue micro-architecture delineation and intracellular data acquisition.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Arcturus Therapeutics
Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
ANA Therapeutics
ANA Therapeutics is a biotech company that is developing a novel coronavirus vaccine intended to save human lives.
ALTATHERA Pharmaceuticals
ALTATHERA Pharmaceuticals provides critical care and alternative therapeutics for unmet medical needs of patients.
Akarna Therapeutics
At Akarna, our mission is to develop best-in-class treatments for NASH and other chronic liver diseases
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Protara Therapeutics
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
eNeura Therapeutics
ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Tarveda Therapeutics
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
BlueLight Therapeutics
BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets.
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform.
Trellis Bioscience
Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.
Thermogenesis
Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
Tallac Therapeutics
Tallac Therapeutics offers next generation immunotherapies for cancer patients.
Therabron
Therabron Therapeutics, we are working to change how respiratory diseases are managed.
Titan Pharmaceuticals
Titan Pharmaceuticals develops proprietary therapeutics for the treatment of serious medical disorders.
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
JW Therapeutics
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
Jecure Therapeutics
Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Qool Therapeutics
Qool Therapeutics is dedicated to creating non-invasive, efficient temperature management therapies to preserve cells.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Qlaris Bio
Qlaris Bio focuses on developing novel and innovative therapies for serious and debilitating ophthalmic diseases.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Kintara Therapeutics
Kintara Therapeutics is a developer of novel cancer therapies for patients with unmet medical needs.
Wilson Therapeutics
Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Serina Therapeutics
Serina Therapeutics employs its proprietary polymer technology to develop treatments for cancer, inflammation, pain and metabolic disorders.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Symbiotix Biotherapies
Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.
CHF Solutions
CHF Solutions is a medical device company that focuses on innovative cardiac assist therapy to treat patients.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Kintara Therapeutics
Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Horizon Pharma
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
iVIEW Therapeutics
IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Immune-Onc Therapeutics
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
InVivo Therapeutics
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
Intellia Therapeutics
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Inspyr Therapeutics
Inspyr Therapeutics is a clinical stage company focused on novel targeted precision therapeutics for the treatment of cancer.
Genomics
Genomics plc aiming to lead the genomic transformation of healthcare.
Ocugenix
Ocugenix is a therapeutics company that develops treatments for angio-fibrotic diseases of the eye.
Opsonix
Opsonix is a developer of a pathogen-extracting therapy designed to transform the treatment of bloodstream infections and sepsis.
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
C2 Therapeutics
C2 Therapeutics develops ablation therapies to treat diseases of the gastrointestinal tract.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Plus Therapeutics
Plus Therapeutics is a clinical-stage pharmaceutical company that develops targeted therapies to treat cancer and other serious diseases.
Corvidia
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Cardioxyl Pharmaceuticals
Cardioxyl Pharmaceuticals discovers, develops and commercializes therapies for the treatment of cardiovascular disease.
Convelo Therapeutics
Convelo Therapeutics is committed to developing medicines to regenerate myelin around nerve cells and restoring function.
Astria Therapeutics
Astria Therapeutics discovers and develops innovative drugs for treating inflammatory conditions.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Y-mAbs Therapeutics
YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.
Current Advisors List
Board_member
Board_member
Current Employees Featured
David Cordo CFO @ Semma Therapeutics
CFO
Douglas Melton Co-founder @ Semma Therapeutics
Co-founder
David Lebwohl CMO @ Semma Therapeutics
CMO
Mary Kay Fenton COO & CFO @ Semma Therapeutics
COO & CFO
2020-01-01
David Digiusto CTO @ Semma Therapeutics
CTO
2018-08-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-11-16 | CytoSolv | CytoSolv acquired by Semma Therapeutics | N/A |
Investors List
Sinopharm Capital
Sinopharm Capital investment in Series B - Semma Therapeutics
MPM Capital
MPM Capital investment in Series B - Semma Therapeutics
6 Dimensions Capital
6 Dimensions Capital investment in Series B - Semma Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Semma Therapeutics
ORI Capital
ORI Capital investment in Series B - Semma Therapeutics
Wu Capital
Wu Capital investment in Series B - Semma Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Semma Therapeutics
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Semma Therapeutics
JDRF T1D Fund
JDRF T1D Fund investment in Series B - Semma Therapeutics
Cowen Group
Cowen Group investment in Series B - Semma Therapeutics
Official Site Inspections
http://www.semma-tx.com
- Host name: 165.160.15.20
- IP address: 165.160.15.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Semma Therapeutics"
Semma Therapeutics - Crunchbase Company Profile & Funding
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a …See details»
Semma Therapeutics Company Profile - Office Locations ... - Craft
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections. Recent work in the laboratory of Professor Douglas Melton led to …See details»
Semma Therapeutics 2025 Company Profile: Valuation, …
Www.semma-tx.com. Ownership Status. Acquired/Merged. Financing Status. Formerly VC-backed. Corporate Office. 100 Technology Square; Floor 3; Cambridge, MA 02139; United States ... Semma Therapeutics was acquired …See details»
Semma Therapeutics Company Overview, Contact Details
Nov 1, 2017 For more information, visit www.semma-tx.com. Sign up for free to view info. Email Format Employee directory . Company Overview. Headquarters 100 Technology Sq …See details»
Semma Therapeutics Receives Investment from JDRF T1D Fund
J.imbaro@semma-tx.com 857-529-6430. JDRF T1D Fund Amy Montalto, National Director amontalto@jdrf.org 617-910-7542. ... the leading global T1D research and advocacy …See details»
Semma Therapeutics - Overview, News & Similar companies
Jul 1, 2019 Who is Semma Therapeutics. Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of …See details»
Semma Therapeutics CEO and Key Executive Team | Craft.co
Semma Therapeutics's CEO is Bastiano Sanna. Other executives include David Lebwohl, Chief Medical Officer; David DiGiusto, CTO and 5 others. See the full leadership team at Craft. ...See details»
Semma Therapeutics - 2025 Company Profile - Tracxn
Feb 27, 2025 Semma Therapeutics - Provider of bio-artificial pancreas for Type 1 Diabetes treatment. Acquired by Vertex Pharmaceuticals. Raised a total funding of $158M over 3 …See details»
Semma Therapeutics - VentureRadar
Semma Therapeutics is working to bring new therapeutic options to the clinic and improve the lives of patients. Ongoing research at Semma Therapeutics is focused on combining these …See details»
Semma Therapeutics (USA) Funding: $163M - Medical Startups
Mar 24, 2025 Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin...See details»
Semma Therapeutics – Funding, Valuation, Investors, News
Semma Therapeutics, a Cambridge, MA-based biotechnology company focused on the development of novel regenerative medicines, completed a $114m Series B financing. The …See details»
Semma Therapeutics’s Competitors, Revenue, Number of ... - Owler
Semma Therapeutics’s Profile, Revenue and Employees. Semma Therapeutics is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of …See details»
Semma Therapeutics - Golden
Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells. Overview Structured Data Issues Contributors Activity. Contents. semma-tx.com. Is …See details»
Semma therapeutics information - Employees, Contact info
View information on-Semma therapeutics (semma-tx.com),Located in 450 Kendall St. Ste. 2B, Cambridge, Massachusetts 02142, US. Find over 6 employees information, adress, official …See details»
Semma Therapeutics - VentureRadar
Nov 30, 2018 Semma Therapeutics is working to bring new therapeutic options to the clinic and improve the lives of patients. Ongoing research at Semma Therapeutics is focused on …See details»
semma-tx.com Reviews | check if site is scam or legit| Scamadviser
Check semma-tx.com with our free review tool and find out if semma-tx.com is legit and reliable. Need advice? Report scams Check Scamadviser! Report a Scam Help & Info API & Data …See details»
Semma Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Semma Therapeutics. See Semma Therapeutics company profile and funding data.See details»
SEMMA THERAPEUTICS ANNOUNCES $44 MILLION IN FUNDING …
Mar 24, 2015 CAMBRIDGE, Mass. – Semma Therapeutics, a company developing a cell therapy for Type 1 diabetes, announced today that it has closed a $44 million Series A …See details»
Semma Therapeutics – Funding, Valuation, Investors, News
Jul 17, 2021 Essential stats, news, real-time insights on Semma Therapeutics. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Semma Therapeutics, Inc. (Semma Therapeutics, Inc.) - 药物管线_ …
Vertex Pharmaceuticals picked up Semma Therapeutics, an ORI invested company, in 2019 for access to its stem cell-derived human islets as a potential cure for type 1 diabetes. Two more …See details»